Luo YY - Search Results

1

An intron mutation in the ACVRL1 may be associated with a transcriptional regulation defect in a Chinese family with hereditary hemorrhagic telangiectasia.

Yu Q, Shen XH, Li Y, Li RJ, Li J, Luo YY, Liu SF, Deng MY, Pei MF, Zhang GS. Yu Q, et al. Among authors: luo yy. PLoS One. 2013;8(2):e58031. doi: 10.1371/journal.pone.0058031. Epub 2013 Feb 27. PLoS One. 2013. PMID: 23460919 Free PMC article.

2

Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes.

Liu X, Zhang G, Yi Y, Xiao L, Pei M, Liu S, Luo Y, Zhong H, Xu Y, Zheng W, Shen J. Liu X, et al. Leuk Lymphoma. 2013 Nov;54(11):2466-73. doi: 10.3109/10428194.2013.778408. Epub 2013 Mar 27. Leuk Lymphoma. 2013. PMID: 23432690

3

Deregulation of mitochondrial ATPsyn-β in acute myeloid leukemia cells and with increased drug resistance.

Xiao X, Yang J, Li R, Liu S, Xu Y, Zheng W, Yi Y, Luo Y, Gong F, Peng H, Pei M, Deng M, Zhang G. Xiao X, et al. PLoS One. 2013 Dec 31;8(12):e83610. doi: 10.1371/journal.pone.0083610. eCollection 2013. PLoS One. 2013. PMID: 24391795 Free PMC article.

4

[The frequency of JAK2 V617F mutation, expression level of phosphorylated JAK/STATs proteins and their clinical significance in myeloproliferative disorders patients].

Hu GY, Deng MY, Zhang GS, Luo YY, Zhu JF. Hu GY, et al. Among authors: luo yy. Zhonghua Xue Ye Xue Za Zhi. 2009 Jun;30(6):394-8. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19951533 Chinese.

5

A TET2 rs3733609 C/T genotype is associated with predisposition to the myeloproliferative neoplasms harboring JAK2(V617F) and confers a proliferative potential on erythroid lineages.

Shen XH, Sun NN, Yin YF, Liu SF, Liu XL, Peng HL, Dai CW, Xu YX, Deng MY, Luo YY, Zheng WL, Zhang GS. Shen XH, et al. Among authors: luo yy. Oncotarget. 2016 Feb 23;7(8):9550-60. doi: 10.18632/oncotarget.7072. Oncotarget. 2016. PMID: 26843622 Free PMC article.

6

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

Zhu S, Wang Z, Li Z, Peng H, Luo Y, Deng M, Li R, Dai C, Xu Y, Liu S, Zhang G. Zhu S, et al. Oncotarget. 2015 Apr 30;6(12):10460-72. doi: 10.18632/oncotarget.3399. Oncotarget. 2015. PMID: 25865044 Free PMC article.

7

A small molecular compound CC1007 induces cross-lineage differentiation by inhibiting HDAC7 expression and HDAC7/MEF2C interaction in BCR-ABL1^- pre-B-ALL.

Wang Z, Zhang Y, Zhu S, Peng H, Chen Y, Cheng Z, Liu S, Luo Y, Li R, Deng M, Xu Y, Hu G, Chen L, Zhang G. Wang Z, et al. Cell Death Dis. 2020 Sep 10;11(9):738. doi: 10.1038/s41419-020-02949-1. Cell Death Dis. 2020. PMID: 32913188 Free PMC article.

8

Proteomic profiling of plasma exosomes from patients with B-cell acute lymphoblastic leukemia.

Zhu S, Xing C, Li R, Cheng Z, Deng M, Luo Y, Li H, Zhang G, Sheng Y, Peng H, Wang Z. Zhu S, et al. Sci Rep. 2022 Jul 13;12(1):11975. doi: 10.1038/s41598-022-16282-4. Sci Rep. 2022. PMID: 35831551 Free PMC article.

9

LncRNA-NEAT1 promotes proliferation of T-ALL cells via miR-146b-5p/NOTCH1 signaling pathway.

Luo YY, Wang ZH, Yu Q, Yuan LL, Peng HL, Xu YX. Luo YY, et al. Pathol Res Pract. 2020 Nov;216(11):153212. doi: 10.1016/j.prp.2020.153212. Epub 2020 Sep 13. Pathol Res Pract. 2020. PMID: 33010698

10

A novel NAP1L4/NUTM1 fusion arising from translocation t(11;15)(p15;q12) in a myeloid neoplasm with eosinophilia and rearrangement of PDGFRA highlights an unusual clinical feature and therapeutic reaction.

Cheng Z, Luo Y, Zhang Y, Wang Y, Chen Y, Xu Y, Peng H, Zhang G. Cheng Z, et al. Ann Hematol. 2020 Jul;99(7):1561-1564. doi: 10.1007/s00277-020-04000-x. Epub 2020 May 26. Ann Hematol. 2020. PMID: 32451710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters